Re Omicron-specific boosters—I’d love some ideas about what to do here. Orgs like 1DaySooner are helpful for advocacy but I don’t see any path to the kind of speed we need here.
“I believe, in principle, we will at a certain time point need a new vaccine against this new variant. The question is how urgent this needs to be available,” CEO Ugur Sahin told a conference hosted by Reuters.
I’m struggling to see a plausible intervention at all here.
(This is Dave Orr, on the board at Packard.)
(Copied from below from before there was this thread.)
Sorry, just saw this! This did not in fact work out on the hoped-for timeline, and I didn’t have a grantee in mind—I think the right way to try to do something here would’ve been through direct dialogue with policymakers.
Re Omicron-specific boosters—I’d love some ideas about what to do here. Orgs like 1DaySooner are helpful for advocacy but I don’t see any path to the kind of speed we need here.
And even Pfizer seems to think that there isn’t a reason for urgency right now (WaPo):
I’m struggling to see a plausible intervention at all here.
(This is Dave Orr, on the board at Packard.)
(Copied from below from before there was this thread.)
Sorry, just saw this! This did not in fact work out on the hoped-for timeline, and I didn’t have a grantee in mind—I think the right way to try to do something here would’ve been through direct dialogue with policymakers.